Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation.

Jeanne MoorMichael KuhneGiorgio MoschovitisRichard KobzaSeraina NetzerAngelo AuricchioJuerg H BeerLeo BonatiTobias ReichlinDavid ConenStefan OsswaldNicolas RodondiCarole ClairChristine BaumgartnerCarole Elodie Aubert

Published in: Open heart (2024)

In this study of patients with AF, doses of beta-blockers and RAS inhibitors did not differ by sex and were not associated with MACE overall.

Keyphrases

atrial fibrillation
heart failure
catheter ablation
left atrial
left atrial appendage
direct oral anticoagulants
angiotensin converting enzyme
emergency department
percutaneous coronary intervention
coronary artery disease
acute coronary syndrome
adverse drug
mitral valve